Investigating B and CD4 T Cell Roles in Multiple Sclerosis
Official title: Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
Run by University Hospital, Bordeaux · NCT04798651 · Data updated 2026-11-12
This study is trying to understand how certain immune cells affect multiple sclerosis in patients to help find better treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 1 site (Bordeaux) |
| Status | Recruiting |
| Started | September 30, 2021 |
| Main results expected | September 2027 |
| Study ends | September 2027 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT04798651 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older diagnosed with multiple sclerosis or clinically isolated syndrome.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or unable to provide consent due to legal restrictions will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to identify the pathogenic properties of B and CD4 T cell subsets in patients with multiple sclerosis (MS) and clinically isolated syndrome (CIS). By analyzing blood and cerebro-spinal fluid samples from 150 participants, the researchers will explore the immune mechanisms involved in different forms of MS. The goal is to enhance understanding of disease progression and potentially develop new therapeutic strategies. The study is conducted at Bordeaux University Hospital, focusing on the immune response in MS patients.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that more effectively halt the progression of multiple sclerosis.
How similar studies have gone: While there have been studies investigating immune cell roles in MS, this specific approach focusing on B and CD4 T cell subsets is novel and may provide new insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * male or female subjects ; * Age ≥ 18 years; * subjects with MS defined by 2010 revised McDonald criteria or presenting a clinical isolated syndrome; * patients for which a blood draw and / or lumbar puncture to collect CSF is performed for diagnostic or therapeutic purpose; * affiliated to an health insurance system; * and who agree to participate in the study. Exclusion Criteria: * Pregnant or breastfeeding women, * patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent)
Where it's running
-
CHU de Bordeaux - service de neurologie
Bordeaux, France Recruiting
Study contacts
- Principal investigator: Aurélie RUET, Prof — University Hospital, Bordeaux
- Study coordinator: Aurélie RUET, Prof
- Email: aurelie.ruet@chu-bordeaux.fr
- Phone: 05 56 79 55 21
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnancy registry for women with chronic neurological conditions
This study is collecting information and samples from pregnant women with chronic neurological conditions to see how pregnancy affects their health and their baby's development.
-
Using optic nerve imaging to predict progression after a first demyelinating episode
This trial will try a dedicated optic nerve MRI in people who recently had a first demyelinating event (clinically isolated syndrome) to see if optic nerve involvement predicts who will have a second relapse and be diagnosed with multiple sclerosis.
-
AI-assisted care for Multiple Sclerosis
This study is testing whether using AI can help doctors better diagnose and treat people with Multiple Sclerosis by analyzing real-world data.
-
Investigating risk factors for disability progression in Multiple Sclerosis
This study is trying to find out what factors might make disability get worse in people with Multiple Sclerosis by looking at their medical history and MRI scans.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.